FIGURE

Fig. 4

ID

ZDB-FIG-250526-43

Publication

Efthymiou et al., 2025 - Biallelic pathogenic variants in TRMT1 disrupt tRNA modification and induce a neurodevelopmental disorder

Other Figures

All Figure Page

Back to All Figure Page

Fig. 4

Human cell lines with bi-allelic TRMT1 variants exhibit a reduction in m2,2G modifications in tRNAs (A and B) Representative gels of primer extension assays to monitor the presence of m2,2G in tRNA-Met-CAU and mt-tRNA-Ile-GAU from the indicated cell lines. m3C20, 3-methylcytosine; m2,2G26, dimethylguanosine; m1G9, 1-methylguanosine. “>” points to labeled oligonucleotide used for primer extension; asterisk denotes background signal. (C–F) Quantification of m2,2G formation by primer extension for the indicated tRNAs. % m2,2G RT block represents the m2,2G stop signal divided by the sum of the m2,2G and read-through m3C or m1G stop signal. The number of replicates is shown in each bar graph with a minimum of two replicates per cell line. Error bars represent standard deviation from the mean. Statistical analysis was performed using one-way ANOVA. For (C) and (D), the mean of each column was compared to the control 1 cell line. For (E) and (F), the mean of each column was compared to the control 2 cell line. ∗p ≤ 0.05, ∗∗p ≤ 0.01, ∗∗∗p ≤ 0.001, ∗∗∗∗p < 0.0001; ns, non-significant (p > 0.05).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Am. J. Hum. Genet.